US Patent Issued to INTRA-CELLULAR THERAPIES on May 13 for "Substituted heterocycle fused gamma-carbolines synthesis" (New Jersey Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,200, issued on May 13, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Substituted heterocycle fused gamma-carbolines synthesis" was invented by Peng Li (New Milford, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides improved methods for the preparation of substituted heterocycle fused gamma-carbolines, intermediates useful in producing them and methods for producing such intermediates and such heterocycle fused gamma-carbolines."

The patent was filed on Dec. 17, 2019, under Application No. 17/415,400.

*For further information, including images, charts and tables, please visit: http://patft.uspto...